Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Sponsors › Genomics: Clinical Implementation › New York to Reduce TB Susceptibility Testing Based on Whole-Genome Sequencing Data

New York to Reduce TB Susceptibility Testing Based on Whole-Genome Sequencing Data

Aug 29, 2018
Premium

NEW YORK (360Dx) – The New York State Department of Health is planning to stop conducting drug susceptibility testing for tuberculosis isolates that are determined to be pan-susceptible through whole-genome sequencing.

The move, which NYSDOH says it is able to do because of the accuracy and the comprehensiveness of its whole-genome sequencing data, is expected to save time and money, and free staff to explore other areas of tuberculosis testing that have not been as thoroughly investigated, according to lab officials.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In Clinical Lab Management

  1. Lab Stakeholders Welcome Biden Moves on COVID-19 Testing, Suggest Additional Steps

    Premium

  2. SARS-CoV-2 Test Pooling Hampered by High Positive Rates, Logistical Hurdles

    Premium

  3. Hamilton Storage, Harvard Spinout Rhinostics Partner for High-Throughput Sample Processing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.